Benjamin William Caulier
Postdoktor
-
Senter for kreftcelle-reprogrammering
English version of this page
E-post
b.w.caulier@medisin.uio.no
Brukernavn
Besøksadresse
Ullernchausséen 70
0379 Oslo
Postadresse
Postboks 4950
0424 Oslo
My research project is focused on the development of an innovative anti-cancer modality, the Chimeric Antigen Receptor (CAR) therapy. This approach harnesses the potential of patients’ own immune cells to specifically kill their cancer. Practically, patients’ lymphocytes are modified with an innovative receptor (the CAR) to be redirected against a tumor antigen. The main goal of my project is to identify novel “targetable” antigens and develop innovative CAR designs to address the impediments of current CAR therapy especially against solid tumors.
Publikasjoner
-
Forcados, Christopher; Joaquina, Sandy; Casey, Nicholas Paul; Caulier, Benjamin William & Wälchli, Sébastien (2022). How CAR T cells breathe. Cells. ISSN 2073-4409. 11:1454(9), s. 1–16. doi: 10.3390/cells11091454.
-
Caulier, Benjamin William; Enserink, Jorrit & Wälchli, Sébastien (2021). Pharmacologic control of CAR T cells. International Journal of Molecular Sciences. ISSN 1661-6596. 22(9), s. 1–23. doi: 10.3390/ijms22094320. Fulltekst i vitenarkiv
Publisert 7. apr. 2021 15:40
- Sist endret 7. okt. 2021 11:07